Testicular germ cell tumour cells release microRNA‐containing extracellular vesicles that induce phenotypic and genotypic changes in cells of the tumour microenvironment
Luz Alonso‐Crisostomo,Jennifer Trendell,Marta Ferraresso,Shivani Bailey,Dawn Ward,Zachary G. L. Scurlock,Stephanie C. Wenlock,Carlos A. P. Bastos,Ravin Jugdaohsingh,Nuno J. Faria,Anton J. Enright,Cinzia G. Scarpini,Nicholas Coleman,Matthew J. Murray
DOI: https://doi.org/10.1002/ijc.34697
2023-08-28
International Journal of Cancer
Abstract:What's new? Testicular germ cell tumours (TCGTs) are characterised by overexpression of certain microRNAs, short non‐coding RNAs that regulate gene expression by binding to mRNA molecules. TCGT cells release these microRNAs into the bloodstream in extracellular vesicles (EVs). Here, the authors showed that EVs released from the tumour cells can deliver microRNAs into cells of the tumour microenvironment, potentially contributing to tumour progression. The authors suggest that these microRNA‐containing EVs could be useful as clinical biomarkers or potential therapeutic targets. Malignant germ‐cell‐tumours (GCTs) are characterised by microRNA (miRNA/miR‐) dysregulation, with universal over‐expression of miR‐371~373 and miR‐302/367 clusters regardless of patient age, tumour site, or subtype (seminoma/yolk‐sac‐tumour/embryonal carcinoma). These miRNAs are released into the bloodstream, presumed within extracellular‐vesicles (EVs) and represent promising biomarkers. Here, we comprehensively examined the role of EVs, and their miRNA cargo, on (fibroblast/endothelial/macrophage) cells representative of the testicular GCT (TGCT) tumour microenvironment (TME). Small RNA next‐generation‐sequencing was performed on 34 samples, comprising representative malignant GCT cell lines/EVs and controls (testis fibroblast [Hs1.Tes] cell‐line/EVs and testis/ovary samples). TME cells received TGCT co‐culture, TGCT‐derived EVs, and a miRNA overexpression system (miR‐371a‐OE) to assess functional relevance. TGCT cells secreted EVs into culture media. MiR‐371~373 and miR‐302/367 cluster miRNAs were overexpressed in all TGCT cells/subtypes compared with control cells and were highly abundant in TGCT‐derived EVs, with miR‐371a‐3p/miR‐371a‐5p the most abundant. TGCT co‐culture resulted in increased levels of miRNAs from the miR‐371~373 and miR‐302/367 clusters in TME (fibroblast) cells. Next, fluorescent labelling demonstrated TGCT‐derived EVs were internalised by all TME (fibroblast/endothelial/macrophage) cells. TME (fibroblast/endothelial) cell treatment with EVs derived from different TGCT subtypes resulted in increased miR‐371~373 and miR‐302/367 miRNA levels, and other generic (eg, miR‐205‐5p/miR‐148‐3p) and subtype‐specific (seminoma, eg, miR‐203a‐3p; yolk‐sac‐tumour, eg, miR‐375‐3p) miRNAs. MiR‐371a‐OE in TME cells resulted in increased collagen contraction (fibroblasts) and angiogenesis (endothelial cells), via direct mRNA downregulation and alteration of relevant pathways. TGCT cells communicate with nontumour stromal TME cells through release of EVs enriched in oncogenic miRNAs, potentially contributing to tumour progression.
oncology